Avid Bioservices (CDMO)
(Real Time Quote from BATS)
$6.74 USD
+0.31 (4.82%)
Updated Apr 23, 2024 02:25 PM ET
5-Strong Sell of 5 5
F Value D Growth B Momentum F VGM
Income Statements
Fiscal Year end for Avid Bioservices, Inc falls in the month of April .
All items in Millions except EPS data.
4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 | 4/30/19 | |
---|---|---|---|---|---|
Sales | 149 | 120 | 96 | 60 | 54 |
Cost Of Goods | 118 | 83 | 67 | 56 | 46 |
Gross Profit | 31 | 37 | 29 | 4 | 7 |
Selling & Adminstrative & Depr. & Amort Expenses | 28 | 21 | 17 | 15 | 13 |
Income After Depreciation & Amortization | 4 | 15 | 12 | -11 | -6 |
Non-Operating Income | 1 | 0 | 0 | 0 | 0 |
Interest Expense | 3 | 3 | 1 | 0 | 0 |
Pretax Income | 2 | 13 | 11 | -10 | -5 |
Income Taxes | 1 | -115 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1 | 128 | 11 | -10 | -5 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 1 |
Net Income (GAAP) | 1 | 128 | 11 | -10 | -4 |
Depreciation Footnote | 4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 | 4/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 12 | 21 | 17 | -8 | -3 |
Depreciation & Amortization (Cash Flow) | 8 | 6 | 4 | 3 | 3 |
Income After Depreciation & Amortization | 4 | 15 | 12 | -11 | -6 |
Earnings Per Share Data | 4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 | 4/30/19 |
---|---|---|---|---|---|
Average Shares | 63.78 | 70.47 | 59.43 | 56.33 | 55.98 |
Diluted EPS Before Non-Recurring Items | 0.02 | 0.27 | 0.06 | -0.27 | -0.17 |
Diluted Net EPS (GAAP) | 0.01 | 1.84 | 0.06 | -0.27 | -0.16 |
Fiscal Year end for Avid Bioservices, Inc falls in the month of April .
All items in Millions except EPS data.
1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 | |
---|---|---|---|---|---|
Sales | NA | 25.40 | 37.73 | 39.80 | 38.02 |
Cost Of Goods | NA | 30.06 | 33.63 | 31.41 | 28.19 |
Gross Profit | NA | -4.66 | 4.10 | 8.39 | 9.83 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 6.56 | 6.26 | 7.56 | 7.11 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -11.22 | -2.16 | 0.83 | 2.72 |
Non-Operating Income | NA | 0.14 | 0.26 | 0.43 | 0.43 |
Interest Expense | NA | 0.81 | 0.78 | 0.76 | 0.62 |
Pretax Income | NA | -11.89 | -2.68 | 0.45 | 2.53 |
Income Taxes | NA | -2.38 | -0.59 | 0.76 | 2.07 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -9.51 | -2.09 | -0.31 | 0.46 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -9.51 | -2.09 | -0.31 | 0.46 |
Earnings Per Share Data | 1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 63.15 | 62.84 | 62.59 | 63.73 |
Diluted EPS Before Non-Recurring Items | NA | -0.15 | -0.03 | 0.00 | 0.03 |
Diluted Net EPS (GAAP) | NA | -0.15 | -0.03 | 0.00 | 0.01 |